Approval · Notice of Compliance 10814 · 2009
COVERSYL: Notice of Compliance 10814
Issued November 30, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10814
- Date
- November 30, 2009
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: orally disintegrating tablets
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
Medicinal ingredients
- PERINDOPRIL ARGININE 2.5 MG per TAB
- PERINDOPRIL ARGININE 5 MG per TAB
- PERINDOPRIL ARGININE 10 MG per TAB